≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Hyperprolactinaemia, drug-induced

PheWeb

E4_HYPERPRO_ADVERSE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 E22.1#

944

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10

152

diagram downward connector

Check minimum number of events None

152

diagram downward connector

Include endpoints None

152

diagram downward connector
E4_HYPERPRO_ADVERSE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 E22
Name in latin Hyperprolactinaemia

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 152 132 20
Unadjusted prevalence (%) 0.04 0.07 0.01
Mean age at first event (years) 38.75 36.85 51.25

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits:

Survival analyses between endpoints

↥

Plot

before Hyperprolactinaemia, drug-induced
after Hyperprolactinaemia, drug-induced

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hyperprolactinaemia, drug-induced

↥